93219 ⎘
Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with at least one of the oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. N-aryloxyphenylureas
TRAINING AN UNSUPERVISED MEMORY-BASED PREDICTION SYSTEM TO LEARN COMPRESSED REPRESENTATIONS OF AN ENVIRONMENT
#2Activators of Heme Regulated Inhibitor Kinase (HRI)
#3Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH)
#4Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#5Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH)
#6Oil gelator
#7Agonists of protein tyrosine phosphatase SHP-1
#8Developer for thermal recording media and thermal composition media using the same
#9Compounds and methods for treating mammalian gastrointestinal microbial infections
#10OMEGA-CARBOXYARL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
#11Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same
#12PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES
#13Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#14SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF
#15Urea compound, self-assembly of urea compounds, organogel containing self-assembly, and method for producing organogel
#16SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY
#17SUBSTITUTED PHENOXYBENZAMIDES
#18Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
#19Compounds, Compositions and Methods
#20Glucagon Antagonists/Inverse Agonists
#21Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
#22SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#23Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
#24Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#25Histone deacetylase inhibitors
#26Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#274-SUBSTITUTED 2-ARYLOXYPHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS
#28Compounds, compositions, and methods
#29Inhibitors of histone deacetylase
#30Inhibitors of histone deacetylase
#31Glucagon antagonists/inverse agonists
#32Compounds, methods for their preparation and use thereof
#33Compounds, compositions and methods
#34GlyT2 modulators
#35Glucagon antagonists/inverse agonists
#36Urea linker derivatives for use as PPAR modulators